These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 30600353)

  • 1. Towards the future of upper tract urothelial carcinoma surveillance: lessons learnt from bladder cancer urinary biomarkers.
    Gallioli A; Boissier R; Territo A; Breda A
    World J Urol; 2019 Sep; 37(9):1985-1986. PubMed ID: 30600353
    [No Abstract]   [Full Text] [Related]  

  • 2. Urothelial cancer of the urinary bladder: can lessons learned be applied to the upper urinary tract?
    Krabbe LM; Hutchinson RC; Margulis V
    Minerva Urol Nefrol; 2016 Aug; 68(4):396-408. PubMed ID: 26990295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup.
    Sanderson KM; Cai J; Miranda G; Skinner DG; Stein JP
    J Urol; 2007 Jun; 177(6):2088-94. PubMed ID: 17509294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185 patients.
    Picozzi S; Ricci C; Gaeta M; Ratti D; Macchi A; Casellato S; Bozzini G; Carmignani L
    J Urol; 2012 Dec; 188(6):2046-54. PubMed ID: 23083867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upper urinary tract transitional cell carcinoma in patients with bladder carcinoma and associated vesicoureteral reflux.
    Amar AD; Das S
    J Urol; 1985 Mar; 133(3):468-71. PubMed ID: 3973999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular basis of intratumoral heterogeneity of urinary tract urothelial carcinoma].
    Osmanov YI; Gaibov JA; Kogan EA; Rapoport LM
    Urologiia; 2019 Apr; (1):126-130. PubMed ID: 31184030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bladder cancer following upper tract urothelial carcinoma.
    Kauffman EC; Raman JD
    Expert Rev Anticancer Ther; 2008 Jan; 8(1):75-85. PubMed ID: 18095885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour multifocality and grade predict intravesical recurrence after nephroureterectomy in patients with upper urinary tract urothelial carcinoma without a history of bladder cancer.
    Narukawa T; Hara T; Arai E; Komiyama M; Kawahara T; Kanai Y; Fujimoto H
    Jpn J Clin Oncol; 2015 May; 45(5):488-93. PubMed ID: 25681388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of Urothelial Bladder Cancer: Predicting the Future.
    Stadler WM
    J Oncol Pract; 2019 Aug; 15(8):429-430. PubMed ID: 31404513
    [No Abstract]   [Full Text] [Related]  

  • 11. [Subsequent upper urothelial cancer following bladder tumor].
    Kuruma H; Ao T; Murayama M; Mizoguchi H; Koshiba K
    Hinyokika Kiyo; 2002 Apr; 48(4):199-202. PubMed ID: 12048930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological characteristics of patients with upper urinary tract urothelial cancer with loss of immunohistochemical expression of the DNA mismatch repair proteins in universal screening.
    Urakami S; Inoshita N; Oka S; Miyama Y; Nomura S; Arai M; Sakaguchi K; Kurosawa K; Okaneya T
    Int J Urol; 2018 Feb; 25(2):151-156. PubMed ID: 29164703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravesical seeding of upper urinary tract urothelial carcinoma cells during nephroureterectomy: an exploratory analysis from the THPMG trial.
    Ito A; Shintaku I; Satoh M; Ioritani N; Tochigi T; Numata I; Namima T; Kambe K; Kyan A; Ueno S; Katoh S; Adachi H; Yamashita S; Yamaguchi T; Arai Y;
    Jpn J Clin Oncol; 2013 Nov; 43(11):1139-44. PubMed ID: 24006504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of p21-activated kinase 1 expression level in patients with upper urinary tract urothelial carcinoma.
    Kuroda K; Asakuma J; Asano T; Horiguchi A; Isono M; Tsujita Y; Sato A; Seguchi K; Ito K; Asano T
    Jpn J Clin Oncol; 2015 Jan; 45(1):103-10. PubMed ID: 25324479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of fatty acid synthase expression in upper urinary tract urothelial carcinoma.
    Hamada S; Horiguchi A; Asano T; Kuroda K; Asakuma J; Ito K; Asano T; Miyai K; Iwaya K
    Jpn J Clin Oncol; 2014 May; 44(5):486-92. PubMed ID: 24643292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upper tract imaging surveillance is not effective in diagnosing upper tract recurrence in patients followed for nonmuscle invasive bladder cancer.
    Sternberg IA; Keren Paz GE; Chen LY; Herr HW; Donat SM; Bochner BH; Dalbagni G
    J Urol; 2013 Oct; 190(4):1187-91. PubMed ID: 23680310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Increased risk of tumor development in the upper urinary tract following multicentric papillary bladder tumors].
    Rosenthal CL; Zingg EJ
    Urologe A; 1983 May; 22(3):183-5. PubMed ID: 6683901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of urothelial carcinoma.
    Miyazaki J; Nishiyama H
    Int J Urol; 2017 Oct; 24(10):730-734. PubMed ID: 28543959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Organ preservation in cancer of the upper urinary tract].
    Vom Dorp F
    Urologe A; 2019 Jan; 58(1):22-24. PubMed ID: 30649581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomics in upper tract urothelial carcinoma.
    Kammerer-Jacquet SF; Mathieu R; Peyronnet B; Rioux-Leclercq N; Bensalah K
    Curr Opin Urol; 2017 Jan; 27(1):35-40. PubMed ID: 27584028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.